NMS·Healthcare·$57M·#198 / 520 in Healthcare
LUNG Pulmonx Corporation
53SPECULATIVE
CATEGORY BREAKDOWN
GROWTH13
QUALITY60
STABILITY61
VALUATION100
GOVERNANCE48
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+8.0%
13
> 50% strong
Gross Margin
Revenue retained after direct costs
74.2%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
26 months
87
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
104.2%
9
< 25% strong
Price / Sales
Market cap relative to trailing revenue
0.6x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
-51
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
4.7%
37
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+4.9%
70
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE LUNG WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when LUNG's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.